Journal of Hepatology Impact Factor

Journal of Hepatology publishes original papers, reviews, case reports,

and letters concerning clinical and basic research in hepatology. It is the

journal associated with the European Association for the Study of the Liver

(EASL), not Hepatology, Liver International, *Clinical Gastroenterology and

Hepatology*, or a generic liver-medicine title.

The checked primary record establishes the 2025 JIF of 40.1 and the

2025 five-year Impact Factor of 33.1, but it does not supply a complete

annual series for this page. The two values are different citation windows in

the same reporting period, not a year-over-year movement. We therefore do not

publish a historical chart, calculate a prior-year delta, or forecast a future

JIF.

For a grant, promotion, or institutional report, inspect the exact annual row

in licensed Journal Citation Reports. A prior value from a directory or a

different metric does not establish a current JIF trend.

The named failure pattern for this query is metric-window substitution.

The current journal site displays both a two-year JIF of 40.1 and a five-year

Impact Factor of 33.1. They are related but not interchangeable. Calling 33.1

the current impact factor without its five-year label changes the claim.

The same rule applies to query snippets and citations: retain the metric name,

data year, and journal title together. This is an exact-record check, not a

claim that the metrics identify the best outlet for every hepatology paper.

The JIF answers a narrow citation question. CiteScore and the five-year metric

can add context, while the five-day median can describe the pace of past initial

handling. None can determine whether a study has clinically meaningful

hepatology implications, a credible causal comparison, enough mechanistic

depth, or a result that travels across relevant patient populations.

The JIF does not establish an acceptance probability for one author, a required

citation count, a guaranteed decision, an article processing charge, a category

rank, or a recommendation to submit. The five-day median is likewise an

aggregate: it may include editorial decisions, and it does not show that a

paper will enter external review or be published on a particular schedule.

Clarivate describes the JIF as a journal-level ratio of citations to citable

items over the relevant two-year window. It should not be used as a proxy for

the quality of one article or researcher. Use the source and policy required by

the institution when the metric will be reported formally.

Clinical consequence asserted without a decision-grade outcome. A clinical

hepatology claim needs the population, comparison, outcome definition, effect

estimate, uncertainty, and limit on transferability to be easy to inspect. A

biomarker association or surrogate improvement is not automatically a

practice-changing finding.

Mechanistic claim that does not bridge to hepatology. Basic work can fit,

but the biological mechanism and its relevance to liver biology, disease, or

treatment should be visible. A technically sound molecular observation without

a clear hepatology question can be better suited to a different specialist

reader.

Five-day timing treated as a forecast. The journal’s first-decision median

describes past handling. It does not prove that a submission will receive

external review or a decision within five days.

These are Manusights preparation checks based on the journal’s stated clinical

and basic hepatology scope, not claims about confidential editorial practice.

[Run a Journal of Hepatology submission readiness

check](/ai-review?target_journal=Journal%20of%20Hepatology&source_blog=journal-of-hepatology-impact-factor&primary_concern=journal_fit)

before using a metric as a reason to target the journal.

This page was created by the Manusights editorial team after checking the

current journal display. This page helps when the decision is whether a

displayed number is the current standard JIF, a longer-window metric, a

CiteScore, or a timing statistic. It makes the differences visible before the

number is carried into a CV, grant, or submission conversation.

The page owns only the Journal of Hepatology impact-factor lookup. It does not

own submission mechanics, fees, acceptance forecasting, or broad journal

selection. That keeps the metric page from competing with pages built for

different author decisions.

For a formal citation, retain the full title, metric name, year, and source:

"Journal of Hepatology’s 2025 Journal Impact Factor is 40.1, according to its

current journal-insights display."

• Match Journal of Hepatology and the current journal-insights display.
• Describe 40.1 as the 2025 JIF, not a 2026 citation-year value.
• Keep the 33.1 five-year metric and 61.6 CiteScore distinctly labeled.
• Do not use the five-day median as an acceptance or publication promise.
• Verify formal ranks, historical changes, and institutional rules in JCR.

For adjacent clinical context, see the Lancet Oncology journal record, Gastroenterology journal record, and best internal medicine journals shortlist, then use an interdisciplinary manuscript readiness check. These resources do not replace the exact metric lookup.